Intra-Cellular Therapies Inc.
เพิ่มขึ้น

LONG ITCI broken overhead resistance ahead of PDUFA

ที่อัปเดต:
ITCI up 20% on the week and further 30% upside ahead! Looking to test 2019 resistance area around 14.50 ahead of its scheduled PDUFA approval on Dec.27th. TP 2 16.50.
บันทึก
Sold at 42.00 thanks for playing
AMRNAVDLbiotechCVMITCILONGPFETrend Analysis

คำจำกัดสิทธิ์ความรับผิดชอบ